Jeffrey L. Ives Cara Therapeutics, Inc. (CARA) insider trading activity

Jeffrey L. Ives is of Cara Therapeutics, Inc.. Currently has a direct ownership of 198,485 shares of CARA, which is worth approximately $83,363. The most recent transaction as insider was on Jun 04, 2024, when has been sold 150,647 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 198K

0% 3M change

314.91% 12M change

Total Value Held $83,363

Jeffrey L. Ives Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2024	BUY Grant, award, or other acquisition	-	150,647 Added 43.15%	198,485 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	32,362 Added 40.35%	47,838 Common Stock
Jul 15 2022	SELL Open market or private sale	$32,580 $9.05 p/Share	3,600 Reduced 18.87%	15,476 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	11,876 Added 38.37%	19,076 Common Stock
Nov 12 2021	SELL Open market or private sale	$131,207 $16.04 p/Share	8,180 Reduced 53.19%	7,200 Common Stock
Jun 07 2021	SELL Open market or private sale	$32,886 $13.05 p/Share	2,520 Reduced 14.08%	15,380 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	7,200 Added 28.69%	17,900 Common Stock
Nov 19 2020	BUY Grant, award, or other acquisition	$39,375 $15.75 p/Share	2,500 Added 18.94%	10,700 Common Stock

Also insider at

ABOS

Acumen Pharmaceuticals, Inc. Healthcare

Director

JLI

Jeffrey L. Ives

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Value

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cara Therapeutics, Inc.

Track Activities on CARA

Account